INFUSYSTEM HOLDINGS, INC (INFU) Gross Margin
- Gross margin · 12 months: Value 57.45%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 57.45% | Gross profit / revenue. Period ending 2026-06-30. $82.35M ÷ $143.34M × 100 ≈ 57.45% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 82.35M USD | Gross Profit |
| Revenue | 143.34M USD | |
| Cost of products and services | 60.98M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $82.35M | $143.34M | $60.98M | 57.45% |
| 2026-03-31 | $80.81M | $142.40M | $61.59M | 56.75% |
| 2025-12-31 | $80.30M | $143.44M | $63.14M | 55.98% |
| 2025-09-30 | $78.08M | $141.05M | $62.98M | 55.35% |
| 2025-06-30 | $76.30M | $139.89M | $63.58M | 54.55% |
| 2025-03-31 | $73.10M | $137.58M | $64.49M | 53.13% |
| 2024-12-31 | $70.40M | $134.86M | $64.46M | 52.20% |
| 2024-09-30 | $68.90M | $132.78M | $63.89M | 51.89% |
| 2024-06-30 | $65.47M | $129.37M | $63.90M | 50.60% |
| 2024-03-31 | $64.63M | $127.41M | $62.78M | 50.73% |
| 2023-12-31 | $63.11M | $125.78M | $62.68M | 50.17% |
| 2023-09-30 | $64.31M | $122.84M | $58.53M | 52.35% |
| 2023-06-30 | $64.28M | $118.21M | $53.93M | 54.38% |
| 2023-03-31 | $62.74M | $113.52M | $50.78M | 55.27% |
| 2022-12-31 | $62.57M | $109.91M | $47.34M | 56.93% |
| 2022-09-30 | $61.80M | $107.60M | $45.80M | 57.43% |
| 2022-06-30 | $60.84M | $106.89M | $46.05M | 56.92% |
| 2022-03-31 | $60.99M | $104.68M | $43.69M | 58.26% |
| 2021-12-31 | $60.20M | $102.38M | $42.19M | 58.80% |
| 2021-09-30 | $59.88M | $100.57M | $40.69M | 59.54% |
| 2021-06-30 | $59.74M | $99.13M | $39.39M | 60.27% |
| 2021-03-31 | $60.67M | $100.30M | $39.63M | 60.49% |
| 2020-12-31 | $58.76M | $97.39M | $38.63M | 60.33% |
| 2020-09-30 | $56.71M | $94.39M | $37.68M | 60.08% |
| 2020-06-30 | $53.83M | $90.75M | $36.92M | 59.31% |
| 2020-03-31 | $49.20M | $84.47M | $35.27M | 58.25% |
| 2019-12-31 | $46.88M | $81.11M | $34.23M | 57.80% |
| 2019-09-30 | $43.36M | $76.97M | $24.82M | 56.33% |
| 2019-06-30 | $40.79M | $72.16M | $22.58M | 56.53% |
| 2019-03-31 | $39.12M | $68.85M | $20.94M | 56.82% |
| 2018-12-31 | $39.02M | $67.14M | $19.33M | 58.12% |
| 2018-09-30 | $40.50M | $68.47M | $18.93M | 59.16% |
| 2018-06-30 | $42.00M | $69.38M | $18.49M | 60.53% |
| 2018-03-31 | $42.78M | $69.91M | $18.31M | 61.20% |
| 2017-12-31 | $43.36M | $71.08M | $18.37M | 61.01% |
| 2017-09-30 | $42.68M | $69.04M | $17.50M | 61.82% |
| 2017-06-30 | $42.03M | $68.68M | $17.07M | 61.20% |
| 2017-03-31 | $42.83M | $69.86M | $17.24M | 61.31% |
| 2016-12-31 | $44.74M | $70.50M | $16.21M | 63.46% |
| 2016-09-30 | $47.28M | $72.39M | $15.86M | 65.31% |
| 2016-06-30 | $52.63M | $76.34M | $15.43M | 68.95% |
| 2016-03-31 | $52.40M | $74.44M | $14.29M | 70.39% |
| 2015-12-31 | $51.18M | $72.13M | $13.80M | 70.97% |
| 2015-09-30 | $48.83M | $68.85M | $13.39M | 70.92% |
| 2015-06-30 | $47.30M | $66.77M | $13.03M | 70.84% |
| 2015-03-31 | $47.37M | $65.97M | $12.29M | 71.80% |
| 2014-12-31 | $47.35M | $66.49M | $12.16M | 71.22% |
| 2014-09-30 | $47.31M | $67.40M | $12.12M | 70.20% |
| 2014-06-30 | $46.92M | $66.53M | $11.65M | 70.53% |
| 2014-03-31 | $45.33M | $64.82M | $11.59M | 69.93% |
| 2013-12-31 | $43.68M | $62.28M | $11.27M | 70.13% |
| 2013-09-30 | $44.10M | $61.34M | $10.58M | 71.89% |
| 2013-06-30 | $42.95M | $59.77M | $10.21M | 71.86% |
| 2013-03-31 | $42.90M | $59.18M | $9.51M | 72.49% |
| 2012-12-31 | $42.91M | $58.83M | $9.16M | 72.94% |
| 2012-09-30 | $38.99M | $56.64M | $9.23M | 68.84% |
| 2012-06-30 | $38.02M | $56.97M | $9.20M | 66.75% |
| 2012-03-31 | $36.74M | $56.03M | $9.22M | 65.57% |
| 2011-12-31 | $35.35M | $54.64M | $9.13M | 64.71% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $33.55M | $47.23M | $7.73M | 71.03% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2009-12-31 | $28.64M | $38.96M | $6.20M | 73.50% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |